Purpose: To determine quality of life (QOL) and health utility in irradiate
d laryngeal cancer survivors.
Materials and Methods: Over 6 months, consecutive follow-up patients at a c
omprehensive cancer centre completed the QOL questionnaire FACT-H&N and the
time trade-off (TTO) utility instrument.
Results: Inclusion criteria were met by 339 patients, of whom 269 were elig
ible, 245 were approached, and 120 agreed to participate. Most participants
were men (83%) who had received radiotherapy (97%) for Stage I disease (53
%) of the glottis (75%); 7% had undergone total laryngectomy, Participants
differed from nonparticipants only in being younger (mean age, 65 vs. 68 ye
ars, p = 0.0049) and having higher performance status (Karnofsky 88 vs. 84,
p = 0.0012). The average scores for FACT-H&N and the TTO were 124/144 (SD,
14) and 0.90/1.0 (SD, 0.16) respectively. FACT-H&N score was more highly c
orrelated with Karnofsky score (r = 0.43, p = 0.001) than with the TTO (r =
0.29, p = 0.002). Gender predicted QOL (means: M = 125, F = 118), while na
tural speech, no relapses, and more time since initial treatment predicted
higher utility.
Conclusion: The QOL of irradiated laryngeal cancer survivors was reasonably
high and independent of initial disease variables. The QOL questionnaire c
orrelated more strongly with performance status than with utility, suggesti
ng that QOL and utility measures may be perceived differently by patients.
(C) 2000 Elsevier Science Inc.